Intra Cellular Therapies reported $22.21M in Sales Revenues for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Acadia Pharmaceuticals ACAD:US $ 131.61M 16.39M
Adamas Pharmaceuticals ADMS:US 25.9M 3.92M
ALKERMES ALKS:US $ 294.14M 9.58M
Aptinyx Inc APTX:US $ 0 0
Arena Pharmaceuticals ARNA:US $ 0M 0M
Biocryst Pharmaceuticals BCRX:US $ 40.99M 8.96M
Biogen BIIB:US $ 2778.9M 3.9M
Bristol Myers Squibb BMY:US $ 11624M 79M
Cytokinetics CYTK:US $ 5.44M 2.59M
Esperion Therapeutics ESPR:US $ 14.41M 26.25M
Gilead Sciences GILD:US $ 7421M 1204M
Gw Pharmaceuticals GWPH:US $ 152.47M 4.24M
Halozyme Therapeutics HALO:US $ 115.83M 20.62M
Intra Cellular Therapies ITCI:US $ 22.21M 2.16M
JAZZ PHA JAZZ:US $ 838.12M 86.3M
Johnson & Johnson JNJ:US $ 23338M 26M
Marinus Pharmaceuticals MRNS:US 10.11M 8.21M
Minerva Neurosciences NERV:US $ 0 0
Nektar Therapeutics NKTR:US $ 24.92M 3.41M
Neurocrine Biosciences NBIX:US $ 296M 7.1M
Novartis NVS:US $ 13367M 73M
Prothena PRTA:US 139.17M 79.1M
Redhill Biopharma RDHL:US $ 21.61M 0.11M
Supernus Pharmaceuticals SUPN:US $ 148.46M 7.14M
United Therapeutics UTHR:US $ 444.7M 1.8M
Vanda Pharmaceuticals VNDA:US $ 70.1M 2.2M
Zogenix ZGNX:US $ 22.61M 3.82M